News & Events

News &

Tarsier Pharma's CEO, Dr. Daphne Haim-Langford, to Present at HCW's 4th Annual Ophthalmology Virtual Conference

August 15, 2024

We are pleased to announce that Tarsier Pharma will be participating in HCW’s 4th Annual Ophthalmology Virtual Conference, taking place on August 15, 2024.

During the conference:

  • Dr. Daphne Haim-Langford, Founder and CEO of Tarsier, will present a corporate deck.
  • Dr. Haim-Langford will be available for one-on-one meetings with investors.
  • Panel discussions with industry leaders are scheduled.
  • Fireside chats with HCW research analysts are expected.

About Tarsier Pharma

Tarsier Pharma is a clinical stage biopharmaceutical company, focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat immune-mediated blinding diseases in the front and back of the eye.


Investor Relations Tarsier Pharma

[email protected]

Scroll to Top